{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T15:13:36Z","timestamp":1780758816305,"version":"3.54.1"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272026"],"award-info":[{"award-number":["82272026"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003398","name":"Shanxi Scholarship Council of China","doi-asserted-by":"publisher","award":["2022-193"],"award-info":[{"award-number":["2022-193"]}],"id":[{"id":"10.13039\/501100003398","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>The relationship between the triglyceride glucose-body mass index (TyG-BMI) and the incidence of metabolic associated fatty liver disease (MAFLD) is a trending research area. This association is highly important in the realms of healthcare and public health.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Objective<\/jats:title>\n<jats:p>To explore the impact of TyG-BMI on MAFLD and its contribution to the evolution of diverse phenotypes of fatty liver.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Methods<\/jats:title>\n<jats:p>In this cross-sectional study, curve fitting was used to assess the relationships between TyG-BMI and MAFLD as well as different MAFLD phenotypes, and multivariate ordinal logistic regression methods were employed to explore the stability of these relationships.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Results<\/jats:title>\n<jats:p>Curve fitting revealed a nonlinear relationship between TyG-BMI and MAFLD, with a critical threshold of approximately 176.78. Similar relationships were observed between TyG-BMI and different fatty liver phenotypes. Multivariate logistic regression revealed that the TyG-BMI was independently associated with different fatty liver phenotypes (nonfibrotic MAFLD odds ratio (OR) = 11.29; 95% confidence interval (CI) = 8.38\u201315.21, <jats:italic><jats:italic>p<\/jats:italic><\/jats:italic>\u2009&lt;\u20090.001; fibrotic MAFLD OR = 37.24, 95% CI\u2009=\u200925.92\u201353.51, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). Even after full variable adjustment, this relationship remained stable (nonfibrotic MAFLD OR = 5.99, 95% CI\u2009=\u20093.25--11.06, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001; fibrotic MAFLD OR = 5.24, 95% CI\u2009=\u20092.28--12.06, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). Correlation analysis revealed a positive correlation between TyG-BMI and CAP (correlation coefficient, 0.60) and a weak positive correlation with SWE (correlation coefficient, 0.29).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec005\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>The TyG-BMI manifests a nonlinear relationship with the risk of developing distinct MAFLD phenotypes, suggesting its utility as a pivotal metric in the formulation of screening and preventive strategies for MAFLD.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0331140","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T17:30:51Z","timestamp":1760635851000},"page":"e0331140","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["Nonlinear association between TyG-BMI and MAFLD: A cross-sectional study"],"prefix":"10.1371","volume":"20","author":[{"given":"Qiuping","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0610-3636","authenticated-orcid":true,"given":"Yanhong","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,10,16]]},"reference":[{"issue":"1","key":"pone.0331140.ref001","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement","volume":"73","author":"M Eslam","year":"2020","journal-title":"J Hepatol"},{"issue":"5","key":"pone.0331140.ref002","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S2468-1253(20)30091-1","article-title":"Redefining non-alcoholic fatty liver disease: what\u2019s in a name?","volume":"5","author":"Hepatology The Lancet Gastroenterology","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"pone.0331140.ref003","doi-asserted-by":"crossref","DOI":"10.3350\/cmh.2022.0367","article-title":"MAFLD: How is it different from NAFLD?","volume":"29","author":"C Gofton","year":"2023","journal-title":"Clin Mol Hepatol"},{"issue":"12","key":"pone.0331140.ref004","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1111\/liv.14675","article-title":"MAFLD identifies patients with significant hepatic fibrosis better than NAFLD","volume":"40","author":"S Yamamura","year":"2020","journal-title":"Liver Int"},{"issue":"3","key":"pone.0331140.ref005","doi-asserted-by":"crossref","first-page":"720","DOI":"10.3390\/biomedicines10030720","article-title":"Metabolic Syndrome but Not Fatty Liver-Associated Genetic Variants Correlates with Glomerular Renal Function Decline in Patients with Non-Alcoholic Fatty Liver Disease","volume":"10","author":"F Baratta","year":"2022","journal-title":"Biomedicines"},{"issue":"1","key":"pone.0331140.ref006","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/s12933-022-01697-0","article-title":"Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention","volume":"21","author":"X-D Zhou","year":"2022","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"pone.0331140.ref007","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s12072-023-10543-8","article-title":"An international multidisciplinary consensus statement on MAFLD and the risk of CVD","volume":"17","author":"X-D Zhou","year":"2023","journal-title":"Hepatol Int"},{"issue":"6","key":"pone.0331140.ref008","first-page":"972","article-title":"Epidemiology and Clinical Outcomes of Metabolic (Dysfunction)-associated Fatty Liver Disease","volume":"9","author":"H Lin","year":"2021","journal-title":"J Clin Transl Hepatol"},{"issue":"5","key":"pone.0331140.ref009","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1007\/s12072-023-10568-z","article-title":"Current understanding and future perspectives on the impact of changing NAFLD to MAFLD on global epidemiology and clinical outcomes","volume":"17","author":"K Vaz","year":"2023","journal-title":"Hepatol Int"},{"key":"pone.0331140.ref010","doi-asserted-by":"crossref","first-page":"155999","DOI":"10.1016\/j.metabol.2024.155999","article-title":"Global burden of metabolic diseases, 1990-2021","volume":"160","author":"H Zhang","year":"2024","journal-title":"Metabolism"},{"issue":"8","key":"pone.0331140.ref011","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S2468-1253(23)00141-3","article-title":"Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis","volume":"8","author":"FE M\u00f3zes","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"pone.0331140.ref012","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ejrad.2019.07.025","article-title":"Quantification of steatosis in alcoholic and nonalcoholic fatty liver disease: Evaluation of four MR techniques versus biopsy","volume":"118","author":"C Boudinaud","year":"2019","journal-title":"Eur J Radiol"},{"issue":"1","key":"pone.0331140.ref013","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/s41392-022-01073-0","article-title":"Trends in insulin resistance: insights into mechanisms and therapeutic strategy","volume":"7","author":"M Li","year":"2022","journal-title":"Signal Transduct Target Ther"},{"issue":"8","key":"pone.0331140.ref014","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22084156","article-title":"Role of insulin resistance in MAFLD","volume":"22","author":"Y Sakurai","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"6","key":"pone.0331140.ref015","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.jhep.2023.08.030","article-title":"Endocrine aspects of metabolic dysfunction-associated steatotic liver disease (MASLD): Beyond insulin resistance","volume":"79","author":"AL Hutchison","year":"2023","journal-title":"J Hepatol"},{"key":"pone.0331140.ref016","doi-asserted-by":"crossref","first-page":"1034047","DOI":"10.3389\/fonc.2023.1034047","article-title":"A LASSO-based model to predict central lymph node metastasis in preoperative patients with cN0 papillary thyroid cancer","volume":"13","author":"F Zhao","year":"2023","journal-title":"Front Oncol"},{"issue":"5","key":"pone.0331140.ref017","doi-asserted-by":"crossref","first-page":"641","DOI":"10.4093\/dmj.2021.0220","article-title":"Assessment of Insulin Secretion and Insulin Resistance in Human","volume":"45","author":"SY Park","year":"2021","journal-title":"Diabetes Metab J"},{"key":"pone.0331140.ref018","doi-asserted-by":"crossref","first-page":"1083032","DOI":"10.3389\/fendo.2023.1083032","article-title":"Prediction of MAFLD and NAFLD using different screening indexes: A cross-sectional study in U.S. adults","volume":"14","author":"H Peng","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"pone.0331140.ref019","doi-asserted-by":"crossref","first-page":"951689","DOI":"10.3389\/fendo.2022.951689","article-title":"Potential screening indicators for early diagnosis of NAFLD\/MAFLD and liver fibrosis: Triglyceride glucose index-related parameters","volume":"13","author":"Y Xue","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"pone.0331140.ref020","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11030883","article-title":"From NAFLD to MAFLD: Definition, Pathophysiological Basis and Cardiovascular Implications","volume":"11","author":"A Boccatonda","year":"2023","journal-title":"Biomedicines"},{"issue":"21","key":"pone.0331140.ref021","doi-asserted-by":"crossref","DOI":"10.3390\/nu14214505","article-title":"Dietary quality and relationships with metabolic dysfunction-associated fatty liver disease (MAFLD) among United States adults, results from NHANES 2017-2018","volume":"14","author":"T Tian","year":"2022","journal-title":"Nutrients"},{"issue":"4","key":"pone.0331140.ref022","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1053\/j.gastro.2023.05.053","article-title":"Prevalence of Liver Steatosis and Fibrosis in the General Population and Various High-Risk Populations: A Nationwide Study With 5.7 Million Adults in China","volume":"165","author":"S Man","year":"2023","journal-title":"Gastroenterology"},{"issue":"1","key":"pone.0331140.ref023","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12944-023-01902-3","article-title":"Comparison of the diagnostic performance of twelve noninvasive scores of metabolic dysfunction-associated fatty liver disease","volume":"22","author":"H Zou","year":"2023","journal-title":"Lipids Health Dis"},{"key":"pone.0331140.ref024","doi-asserted-by":"crossref","first-page":"1388967","DOI":"10.3389\/fimmu.2024.1388967","article-title":"Positive association between insulin resistance and fatty liver disease in psoriasis: evidence from a cross-sectional study","volume":"15","author":"X Zhong","year":"2024","journal-title":"Front Immunol"},{"issue":"9","key":"pone.0331140.ref025","article-title":"Diagnostic value of triglyceride-glucose index and related parameters in metabolism-associated fatty liver disease in a Chinese population: a cross-sectional study","volume":"13","author":"R Yu","year":"2023","journal-title":"BMJ Open"},{"key":"pone.0331140.ref026","doi-asserted-by":"crossref","first-page":"1308265","DOI":"10.3389\/fendo.2023.1308265","article-title":"Modified triglyceride-glucose index indices are reliable markers for predicting risk of metabolic dysfunction-associated fatty liver disease: a cross-sectional study","volume":"14","author":"AH Kim","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"pone.0331140.ref027","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-070189","article-title":"Association between triglyceride glucose-related markers and the risk of metabolic-associated fatty liver disease: a cross-sectional study in healthy Chinese participants","volume":"13","author":"M Chang","year":"2023","journal-title":"BMJ Open"},{"issue":"1","key":"pone.0331140.ref028","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12944-022-01661-7","article-title":"Comparison of the diagnostic value between triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio in metabolic-associated fatty liver disease patients: a retrospective cross-sectional study","volume":"21","author":"Z Liu","year":"2022","journal-title":"Lipids Health Dis"},{"issue":"1","key":"pone.0331140.ref029","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1186\/s12889-023-15365-9","article-title":"Comparison of the prognostic value of a comprehensive set of predictors in identifying risk of metabolic-associated fatty liver disease among employed adults","volume":"23","author":"Z Yang","year":"2023","journal-title":"BMC Public Health"},{"key":"pone.0331140.ref030","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.2147\/DMSO.S418020","article-title":"Non-Traditional Blood Lipid Indices for Metabolism Dysfunction-Associated Fatty Liver Disease Prediction in Non-Obese Type 2 Diabetes Mellitus","volume":"16","author":"Q Gao","year":"2023","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"25","key":"pone.0331140.ref031","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.3748\/wjg.v29.i25.3999","article-title":"Insulin resistance and adipose tissue interactions as the cornerstone of metabolic (dysfunction)-associated fatty liver disease pathogenesis","volume":"29","author":"SC Pal","year":"2023","journal-title":"World J Gastroenterol"},{"issue":"1","key":"pone.0331140.ref032","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12933-022-01511-x","article-title":"Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations","volume":"21","author":"L-C Tao","year":"2022","journal-title":"Cardiovasc Diabetol"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0331140","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T17:30:56Z","timestamp":1760635856000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0331140"}},"subtitle":[],"editor":[{"given":"Qian","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,10,16]]},"references-count":32,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0331140","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,16]]}}}